INDIANAPOLIS, March 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for agents targeting SMARCA2 (BRM) and multiple KRAS mutations will be ...

Organovo (ONVO) announced the close of the sale of its FXR program, including lead asset FXR314, to Eli Lilly and Company (LLY). The transaction was completed on March 25. With the closing ...

Berenberg Bank analyst Kerry Holford maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on March 21 and set a price target of $970.00. The company’s shares closed last Friday at ...

To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Eli Lilly and Novo Nordisk have scored big wins from the FDA in recent months, as the agency cracks down on ...

We recently published a list of Billionaire Ken Fisher’s Top 13 Growth Stock Picks. In this article, we are going to take a ...

Marta scored on a first-half penalty kick as the Orlando Pride remained undefeated with a 2-0 road victory over NJ/NY Gotham FC in National Women’s Soccer League on Sunday. Also in the other NWSL game ...

CBS Sports' Matt Zenitz reported on Monday that Georgia is targeting former North Carolina tight ends coach John Lilly and former Jacksonville Jaguars offensive line coach Phil Rauscher for roles ...

The height of the draft drama in 1970 might have been the coin flip held Jan. 9 in New Orleans, two days before Super Bowl IV was ... He's fast and big like Bob Lilly. He could go offense or ...

Eli Lilly plans to release key data on its once-daily obesity pill, orforglipron, this year, which could help the company solidify its place in the weight loss and diabetes drug market.